ArticleScientific reports2025
Machine learning-based risk prediction model development for acute kidney injury in type 2 myocardial infarction patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Type 2 myocardial infarction (T2MI), distinguished from Type 1 myocardial infarction (T1MI) by oxygen supply - demand mismatch, has unique features. Acute kidney injury (AKI) following MI leads to severe consequences. Existing research mostly centers on T1MI, leaving a gap in T2MI related AKI studies. To address this, our research aims to explore AKI risk factors in T2MI patients and leverage machine learning algorithms to develop a model for accurate early prediction of AKI risk in this patient group. This retrospective study utilized the MIMIC-IV database (2008-2022) to analyze T2MI patients in critical care. The dataset was split 70:30 for model development. 12 machine learning algorithms underwent Boruta-based feature selection and hyperparameter optimization. All 12 machine learning algorithms were trained independently (i.e., no integration into a SuperLearner or other ensemble learning frameworks was performed). Model performance was assessed via AUROC, with SHAP analysis interpreting predictions, followed by web deployment for clinical use. Among 1,378 critically ill patients, 60.5% developed AKI post-ICU admission. Eleven variables were selected for machine learning modeling. XGBoost demonstrated superior predictive performance (test AUROC: 0.82, 95% CI 0.77-0.86). SHAP analysis identified mechanical ventilation as the strongest predictor, followed by minimum mean arterial pressure, maximum heart rate, maximum aspartate aminotransferase, and minimum white blood cell count. An interactive web tool ( https://qhdpanguo.shinyapps.io/2MI-AKI/ ) was developed for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.